Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapyWen Xu, Annie LM Cheung|Oncotarget|2014Cited by 70
Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasisWen Xu, Bin Li|EBioMedicine|2023Cited by 25